AI and facial diagnosis company FDNA sets up genomics coalition
Boston biotech FDNA has teamed up with several research organizations to create a consortium that will try to apply artificial intelligence and machine learning to the development of new medicines — and is looking for other partners. The Genomics Collaborative launched with the aim of using computational techniques to analyze genotype and phenotype data and try to tease out physiological relationships that could lead to new drug targets and, it says, “help millions of undiagnosed patients globally."
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063